# Nuclide record acrotech-biopharma (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/acrotech-biopharma/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "acrotech-biopharma" ;
  schema:name "Acrotech Biopharma"@en ;
  schema:description "Acrotech Biopharma, part of Aurobindo, owns the former Spectrum Pharmaceuticals haematology portfolio: the radioimmunotherapy Zevalin, pralatrexate (Folotyn), belinostat (Beleodaq) and vincristine liposome (Marqibo)."@en ;
  schema:url <https://nuclide.cc/companies/acrotech-biopharma/>, <https://www.acrotechbiopharma.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.acrotechbiopharma.com> ;
  schema:addressCountry "US" ;
  nuclide:indications <https://nuclide.cc/indications/follicular-lymphoma/> ;
  nuclide:drugs <https://nuclide.cc/drugs/ibritumomab-tiuxetan/> .
